Increased expression of iron-containing superoxide dismutase-A (TcFeSOD-A) enzyme in Trypanosoma cruzi population with in vitro-induced resistance to benznidazole

Acta Tropica

Volumn 100, Issue 1-2, 2006, Pages 119-132

  Nogueira, Fernanda B ^a   Krieger, Marco A ^a   Nirdé, Philippe ^b   Goldenberg, Samuel ^a   Romanha, Alvaro J ^a   Murta, Silvane M F ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b INSERM   (France)

Author keywords

Benznidazole; Differential gene expression; Drug resistance; Iron superoxide dismutase; Trypanosoma cruzi

Indexed keywords

BENZNIDAZOLE; SUPEROXIDE DISMUTASE;

ANALYTICAL METHOD; CLONE; DISEASE RESISTANCE; DRUG; ENZYME ACTIVITY; GENE EXPRESSION; POLYMORPHISM; POPULATION STRUCTURE; PROTOZOAN; RNA;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; DRUG RESISTANCE; ENZYME ACTIVITY; GENETIC ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; TRYPANOSOMA CRUZI;

AMINO ACID SEQUENCE; ANIMALS; CHROMOSOME MAPPING; DRUG RESISTANCE; GENE DOSAGE; HUMANS; MOLECULAR SEQUENCE DATA; NITROIMIDAZOLES; PARASITIC SENSITIVITY TESTS; SEQUENCE ANALYSIS, DNA; SUPEROXIDE DISMUTASE; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI; UP-REGULATION;

TRYPANOSOMA CRUZI;

EID: 33751423139     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2006.10.004     Document Type: Article

References (51)

1. Ahmed H., Schott E.T., Gauthier J.D., and Vasta G.R. Superoxide dismutase from the oyster parasite Perkinsus marinus: purification, biochemical characterization, and development of a plate microassay for activity. Anal. Biochem. 318 (2003) 132-141
2. Allen T., and Ullman B. Molecular characterization and overexpression of the hypoxantine-guanine phosphoribosyltransferase gene from Trypanosoma cruzi. Mol. Biochem. Parasitol. 65 (1994) 233-245
3. Anonymous. Recommendations from a satellite meeting. Mem. Inst. Oswaldo Cruz. 94 (1999) 429-432
4. Bannister J.V., Bannister W.H., and Rotilio G. Aspects of the structure, function and applications of superoxide dismutase. Crit. Rev. Biochem. 22 (1987) 111-180
5. Berger B.J., and Fairlamb A.H. Interactions between immunity and chemotherapy in the treatment of the trypanosomiases and leishmaniases. Parasitology 105 (1992) 871-878
6. Boveris A., and Stoppani A.O. Hydrogen peroxide generation in Trypanosoma cruzi. Experienta 33 (1977) 1306-1308
7. Boveris A., Hertig C.M., and Turrens J.F. Fumarate reductase and other mitochondrial activities in Trypanosoma cruzi. Mol. Biol. Parasitol. 19 (1986) 163-169
8. Buckner F., Wilson A., Whitr T., and Van Voorhis W. Induction of resistance to azole drugs in Trypanosoma cruzi. Antimicrob. Agents Chemoth. 42 (1998) 3245-3250
9. Camargo E. Growth and differentiation in Trypanosoma cruzi. I. Origin of metacyclic trypanosomes in liquid media. Rev. Inst. Med. Trop. 6 (1964) 93-100
10. Christmas P.B., and Turrens J.F. Separation of NADH-fumarate reductase and succinate dehydrogenase activities in Trypanosoma cruzi. FEMS Microb. Letters 183 (2000) 225-228
11. Docampo R., and Moreno S.N. Free radical metabolites in the mode of action of chemotherapeutic agents and phagocytic cells on Trypanosoma cruzi. Rev. Infect. Dis. 6 (1984) 223-238
12. Docampo R. Sensitivity of parasites to free radical damage by antiparasitic drugs. Chem. Biol. Interact. 73 (1990) 1-27
13. Dos Santos W., and Buck G. Polymorphisms at the topoisomerase II gene locus provide more evidence for the partition of Trypanosoma cruzi into two major groups. J. Euk. Microbiol. 46 (1999) 17-23
14. Dufernez F., Yernaux C., Gerbod D., Noël C., Chauvenet M., Wintjens R., Edgcomb V.P., Capron M., Opperdoes F.R., and Viscogliosi E. The presence of four iron-containing superoxide dismutase isozymes in Trypanosomatidae: characterization, subcellular localization, and phylogenetic origin in Trypanosoma brucei. Free Rad. Biol. Med. 40 (2006) 210-225
15. Engel J., Garcia C., Hsieh I., Doyle P., and Mckerrow J. Upregulation of the secretory pathway in cisteine proteaese inhibitor-resistant Trypanosoma cruzi. J. Cell Sci. 113 (2000) 1345-1354
16. Filardi L., and Brener Z. Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease. Trans. R. Soc. Trop. Med. Hyg. 81 (1987) 755-759
17. Finzi J.K., Chiavegatto C.W.M., Corat K.F., Lopez J.A., Cabrera O.G., Mielniczki-Pereira A.A., Colli W., Alves M.J.M., and Gadelha F.R. Trypanosoma cruzi response to the oxidative stress generated by hydrogen peroxide. Mol. Biochem. Parasitol. 133 (2004) 37-43
18. Guimond C., Trudel N., Brochu C., Marquis N., Fadili A.E., Peytavi R., Briand G., Richard D., Messier N., Papadopoulou B., Cordeil J., Bergeron M., Legaré D., and Ouellette M. Modulation of gene expression in Leishmania drug resistant mutants as determined by targeted DNA microarrays. Nucl. Acids Res. 31 (2003) 5886-5896
19. Ismail S.O., Paramchuk W., Skeiky Y.A.W., Reed S.G., Bhatia A., and Gedamu L. Molecular cloning and characterization of two iron superoxide dismutase cDNAs from Trypanosoma cruzi. Mol. Biochem. Parasitol. 86 (1997) 187-197
20. Kabiri M., and Steverding D. Identification of a developmentally regulated iron superoxide dismutase of Trypanosoma brucei. Biochem. J. 360 (2001) 173-177
21. Krieger M.A., and Goldenberg S. Representation of differential expression: a new approach to study differential gene expression in trypanosomatids. Parasitol. Today 14 (1998) 163-166
22. Le Trant N., Meshnick S.R., Kitchener K., Eaton J.W., and Cerami A. Iron-containing superoxide dismutase from Crithidia fasciculata. Purification, characterisation, and similarity to the leishmanial and trypanosomal enzymes. J. Biol. Chem. 258 (1983) 125-130
23. Maya J.D., Repetto Y., Agosín M., Ojeda J.M., Tellez R., Gaule C., and Morillo A. Effects of nifurtimox and benznidazole upon glutathione and trypanothione in epimastigote, trypomastigote and amastigote forms of Trypanosoma cruzi. Mol. Biochem. Parasitol. 86 (1997) 101-106
24. Maya J.D., Bollo S., Nuñez-Vergara L.J., Squella J.A., Repetto Y., Morillo A., Périé J., and Chauvière G. Trypanosoma cruzi: effect and mode of action of nitroimidazole and nitrofuran derivatives. Biochem. Pharmacol. 65 (2003) 999-1006
25. Miller A.F. Superoxide dismutases: active sites that save, but a protein that kills. Curr. Opin. Chem. Biol. 8 (2004) 1-7
26. Moser D.R., Kirchhoff L.V., and Donelson J.E. Detection of Trypanosoma cruzi by DNA amplification using the polymerase chain reaction. J. Clin. Microbiol. 27 (1989) 1477-1482
27. Morello A. The biochemistry of the mode of action of drugs and the detoxication mechanisms in Trypanosoma cruzi. Comp. Biochem. Physiol. C 90 (1988) 1-12
28. Moreno S.N., Docampo R., Mason R.P., Leon W., and Stoppani A.O. Different behaviours of benznidazole as free radical generator with mammalian and Trypanosoma cruzi microsomal preparations. Arch. Biochem. Biophys. 218 (1982) 585-591
29. Murta S.M.F., and Romanha A.J. In vivo selection of a population of Trypanosoma cruzi and clones resistant to benznidazole. Parasitology 116 (1998) 165-171
30. Murta S.M.F., Gazzinelli R., Brener Z., and Romanha A.J. Molecular characterization of susceptible and naturally resistant strains of Trypanosoma cruzi to benznidazole and nifurtimox. Mol. Biochem. Parasitol. 93 (1998) 203-214
31. Murta S.M.F., Dos Santos W.G., Anacleto C., Nirdé P., Moreira E.S.A., and Romanha A.J. Drug resistance in Trypanosoma cruzi is not associated with amplification or overexpression of phosphoglycoprotein (PGP) genes. Mol. Biochem. Parasitol. 117 (2001) 223-228
32. Murta S.M.F., Krieger M.A., Costa V.G., Yamada-Ogatta S.F., Muto N.H., Oliveira R.C., Nunes L.R., Goldenberg S., and Romanha A.J. Functional genomic analysis of drug resistance in Trypanosoma cruzi. Rev. Inst. Med. Trop. São Paulo 44 (2002) 24
33. Murta S.M.F., Krieger M.A., Montenegro L.R., Campos F.F.M., Probst C.M., Ávila A.R., Muto N.H., Oliveira R., Nunes L.R., Nirdé P., Bruna-Romero O., Goldenberg S., and Romanha A.J. Deletion of copies of the gene encoding old yellow enzyme (TcOYE), NAD(P)H flavin oxidoredutase, associates with in vitro-induced benznidazole resistance in Trypanosoma cruzi. Mol. Biochem. Parasitol. 146 (2006) 151-162
34. Neal R.A., and Van Bueren J. Comparative studies of drug susceptibility of five strains of Trypanosoma cruzi in vitro and in vivo. Trans. R. Soc. Trop. Med. Hyg. 82 (1988) 709-714
35. Nirdé P., Larroque C., and Barnabé C. Drug-resistant epimastigotes of Trypanosoma cruzi and persistence of this phenotype after differentiation into amastigotes. CR Acad. Sci. Ser. III 318 (1995) 1239-1244
36. Nozaki T., Engel J., and Dvorak J. Cellular and molecular biological analyses of nifurtimox resistance in Trypanosoma cruzi. Am. J. Med. Hyg. 55 (1996) 111-117
37. Paramchuk W.J., Ismail S.O., Bhatia A., and Gedamu L. Cloning, characterization and overexpression of two iron superoxide dismutase cDNAs from Leishmania chagasi: role in pathogenesis. Mol. Biochem. Parasitol. 90 (1997) 203-221
38. Sambrook J., Fritsch E., and Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed. (1989), Cold Spring Harbor Laboratory Press, Cold Spring Harbor
39. Steenkamp D.J. Thiol metabolism of the trypanosomatids as potential drug targets. IUBMB Life 53 (2002) 243-248
40. Temperton N.J., Wilkinson S.R., and Kelly J.M. Cloning of an Fe-superoxide dismutase gene homologue from Trypanosoma cruzi. Mol. Biochem. Parasitol. 76 (1996) 339-343
41. Temperton N.J., Wilkinson S.R., Meyer D.J., and Kelly J.M. Overexpression of superoxide dismutase in Trypanosoma cruzi results in increased sensitivity to the trypanocidal agents gentian violet and benznidazole. Mol. Biochem. Parasitol. 96 (1998) 167-176
42. Toledo M., Tafuri W., Bahia M.T., Tibayrenc M., and Lana M. Genetic diversity and drug resistance in Trypanosoma cruzi, the agent of Chagas disease. Antimicrob. Agents Chemother. 4 (2004) 11-22
43. Turrens J.F., Watts Jr. B.P., Zhong L., and Docampo R. Inhibition of Trypanosoma cruzi and T. brucei NADH fumarate reductase by benznidazole anthelmintic imidazole derivates. Mol. Biochem. Parasitol. 82 (1996) 125-129
44. Ullman B. Multidrug resistance and P-glicoprotein in parasitic Protozoa. J. Bioenerg. Biomembr. 27 (1995) 77-84
45. Urbina J.A., and Docampo R. Specific chemotherapy of Chagas disease: controversies and advances. Trends Parasitol. 19 (2003) 495-501
46. Vanhame L., and Pays E. Control of gene expression in Trypanosomes. Microbiol. Rev. 59 (1995) 223-240
47. Villarreal D., Nirdé P., Hide M., Barnabé C., and Tibayrenc M. Differential gene expression in benznidazole-resistant Trypanosoma cruzi parasites. Antimicrob. Agents Chemother. 49 (2005) 2701-2709
48. Wassmann C., Hellberg A., Tannich E., and Bruchhaus I. Metronidazole resistance in the protozoan parasite Entamoeba histolytica is associated with increased expression of iron-containing superoxide dismutase and peroxiredoxin and decreased expression of ferredoxin 1 and flavin reductase. J. Biol. Chem. 37 (1999) 26051-26056
49. Wilkinson S.R., Prathalingam S.R., Taylor M.C., Ahmed A., Horn D., and Kelly J.M. Functional characterisation of the iron superoxide dismutase gene repertoire in Trypanosoma brucei. Free Rad. Biol. Med. 40 (2006) 198-209
50. Wintjens R., Noël C., May A.C.W., Gerbod D., Dufernez F., Capron M., Viscogliosi E., and Rooman M. Specificity and phenetic relationships of iron- and manganese-containing superoxide dismutase on the basis of structure and sequence comparisons. J. Biol. Chem. 279 (2004) 9248-9254
51. World Health Organization. 2002. Online: http://www.who.int/ctd/chagas/burdens.htm and http://www.who.int/tdr/diseases/chagas/direction.htm. Accessed November 25, 2005.